Tandem Diabetes Care
TNDM
332 hedge funds and large institutions have $3.1B invested in Tandem Diabetes Care in 2024 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 109 increasing their positions, 118 reducing their positions, and 41 closing their positions.
1,272% more call options, than puts
Call options by funds: $145M | Put options by funds: $10.5M
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
41% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 41
5% more funds holding
Funds holding: 317 → 332 (+15)
5% more capital invested
Capital invested by funds: $2.96B → $3.1B (+$135M)
8% less repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 118
2.27% less ownership
Funds ownership: 113.92% → 111.65% (-2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$44.6M |
| 2 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$19.4M |
| 3 |
Goldman Sachs
New York
|
+$18.2M |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$16.9M |
| 5 |
Millennium Management
New York
|
+$16.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$61.9M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$28.4M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$25.9M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$22.8M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$17M |
TNDM Hedge Fund Activity: Q3 2024 in Review
332 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q3 2024, worth a combined $3.1B — up 4.6% from $2.96B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new TNDM positions and 41 closed out — a net gain of 17 holders — while 109 added to existing stakes and 118 trimmed.
The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $44.6M. The largest seller was Citadel Advisors, cutting an estimated $61.9M.
- 332 institutional investors held Tandem Diabetes Care (TNDM) as of Q3 2024, up from 317 in Q2 2024.
- Funds reported $3.1B of Tandem Diabetes Care stock for Q3 2024, up 4.6% quarter-over-quarter.
- 58 funds opened new Tandem Diabetes Care positions in Q3 2024 and 41 closed out, a net change of +17 holders.
- The largest Tandem Diabetes Care buyer in Q3 2024 was Divisadero Street Capital Management, an estimated $44.6M added.
- The largest Tandem Diabetes Care seller in Q3 2024 was Citadel Advisors, an estimated $61.9M sold.
Based on aggregated 13F filings for Q3 2024.